Elucidation of the Mechanism of Indonesian Traditional Medicine (Jamu) Based on Case Studies of Type 2 Diabetes Networks
| Autor: | Eduward Hottua Hutabarat, Vitri Aprilla Handayani |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
Momordica biology Traditional medicine Natural materials Mechanism (biology) General Engineering Network Type 2 diabetes biology.organism_classification medicine.disease Type 2 Diabetes 03 medical and health sciences Fuzzy Clustering 030104 developmental biology 0302 clinical medicine 030220 oncology & carcinogenesis medicine Zingiber officinale Blumea balsamifera Graph Tri-Partite Medicinal plants Insulin secretion Jamu |
| Zdroj: | International Journal of Engineering and Management Research. 10:87-91 |
| ISSN: | 2250-0758 2394-6962 |
| DOI: | 10.31033/ijemr.10.1.16 |
| Popis: | Plant medicine is a kind of plant that can be used to solve various problems in the human body either due to illness or other disorders. Jamu is an Indonesian traditional medicine. It is essentially herbal medicine that made from natural materials taken from several parts of medicinal plants which contain some substances and compounds that important and beneficial for the body. So far, the efficacy for some type of jamu has been proven empirically. In this paper, to fill this gap, we intend to elucidate the mechanism of jamu using computational base approach. This research focus to a jamu for Type 2 Diabetes (T2D) which prescription consist of four plants: Ginger (Zingiber officinale), Bratawali (Tinospora crispa), Sembung (Blumea balsamifera), and Bitter Melon (Momordica charantia). The framework of analysis starts with generating the network with 3 components: active compounds, proteins target and gene ontology. After that, will implement clustering to those components using concept of tri-partite graphs fuzzy clustering. The main ingredients of 15 active compounds have high score probability which divided in different cluster by the pair of active compounds that have high synergic effect. T2D is not solely caused by protein abnormalities from insulin secretion (isoform insulin-degrading enzyme 1), but also caused by other proteins that involved in the inhibition of insulin in the pancreas. These proteins are Alpha-2C adrenergic receptors, beta-1 adrenergic receptor, and peroxisome proliferator-activated receptor delta, which have high probability in the same group. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|